[Beta-1 blockade plus NO release. Additional organ protection for patients with hypertension].
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology / Q000627:therapeutic use*; D000368:Aged; D000959:Antihypertensive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001578:Benzopyrans / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D018592:Cross-Over Studies; D004983:Ethanolamines / Q000494:pharmacology / Q000627:therapeutic use*; D006321:Heart / Q000187:drug effects; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007668:Kidney / Q000187:drug effects; D000068577:Nebivolol; D009569:Nitric Oxide / Q000502:physiology*; D010865:Pilot Projects; D010919:Placebos; D014665:Vasodilator Agents / Q000494:pharmacology / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D001578:Benzopyrans; D004983:Ethanolamines; D010919:Placebos; D014665:Vasodilator Agents; D000068577:Nebivolol; D009569:Nitric Oxide